These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Scrambling of the amino acids within the transmembrane domain of Vpu results in a simian-human immunodeficiency virus (SHIVTM) that is less pathogenic for pig-tailed macaques. Hout DR, Gomez ML, Pacyniak E, Gomez LM, Inbody SH, Mulcahy ER, Culley N, Pinson DM, Powers MF, Wong SW, Stephens EB. Virology; 2005 Aug 15; 339(1):56-69. PubMed ID: 15975620 [Abstract] [Full Text] [Related]
4. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques. Hout DR, Gomez ML, Pacyniak E, Mulcahy ER, Gomez LM, Jackson M, Flick M, Fegley B, McCormick C, Wisdom BJ, Culley N, Pinson DM, Powers M, Wong SW, Stephens EB. Virology; 2004 May 20; 323(1):91-107. PubMed ID: 15165822 [Abstract] [Full Text] [Related]
5. A molecular clone of simian-human immunodeficiency virus (DeltavpuSHIV(KU-1bMC33)) with a truncated, non-membrane-bound vpu results in rapid CD4(+) T cell loss and neuro-AIDS in pig-tailed macaques. McCormick-Davis C, Dalton SB, Hout DR, Singh DK, Berman NE, Yong C, Pinson DM, Foresman L, Stephens EB. Virology; 2000 Jun 20; 272(1):112-26. PubMed ID: 10873754 [Abstract] [Full Text] [Related]
7. Deletion of the vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques. Stephens EB, McCormick C, Pacyniak E, Griffin D, Pinson DM, Sun F, Nothnick W, Wong SW, Gunderson R, Berman NE, Singh DK. Virology; 2002 Feb 15; 293(2):252-61. PubMed ID: 11886245 [Abstract] [Full Text] [Related]
8. A simian human immunodeficiency virus with a nonfunctional Vpu (deltavpuSHIV(KU-1bMC33)) isolated from a macaque with neuroAIDS has selected for mutations in env and nef that contributed to its pathogenic phenotype. Singh DK, McCormick C, Pacyniak E, Lawrence K, Dalton SB, Pinson DM, Sun F, Berman NE, Calvert M, Gunderson RS, Wong SW, Stephens EB. Virology; 2001 Mar 30; 282(1):123-40. PubMed ID: 11259196 [Abstract] [Full Text] [Related]
9. The presence of the casein kinase II phosphorylation sites of Vpu enhances the CD4(+) T cell loss caused by the simian-human immunodeficiency virus SHIV(KU-lbMC33) in pig-tailed macaques. Singh DK, Griffin DM, Pacyniak E, Jackson M, Werle MJ, Wisdom B, Sun F, Hout DR, Pinson DM, Gunderson RS, Powers MF, Wong SW, Stephens EB. Virology; 2003 Sep 01; 313(2):435-51. PubMed ID: 12954211 [Abstract] [Full Text] [Related]
10. Characterization of a neutralization-escape variant of SHIVKU-1, a virus that causes acquired immune deficiency syndrome in pig-tailed macaques. Narayan SV, Mukherjee S, Jia F, Li Z, Wang C, Foresman L, McCormick-Davis C, Stephens EB, Joag SV, Narayan O. Virology; 1999 Mar 30; 256(1):54-63. PubMed ID: 10087226 [Abstract] [Full Text] [Related]
12. The human immunodeficiency virus type 1 Vpu protein tethered to the CD4 extracellular domain is localized to the plasma membrane and is biologically active in the secretory pathway of mammalian cells: implications for the mechanisms of Vpu function. Raja NU, Jabbar MA. Virology; 1996 Jun 01; 220(1):141-51. PubMed ID: 8659106 [Abstract] [Full Text] [Related]
13. Modulation of the severe CD4+ T-cell loss caused by a pathogenic simian-human immunodeficiency virus by replacement of the subtype B vpu with the vpu from a subtype C HIV-1 clinical isolate. Hill MS, Ruiz A, Pacyniak E, Pinson DM, Culley N, Yen B, Wong SW, Stephens EB. Virology; 2008 Feb 05; 371(1):86-97. PubMed ID: 17950774 [Abstract] [Full Text] [Related]
16. Simian-Human immunodeficiency viruses expressing chimeric subtype B/C Vpu proteins demonstrate the importance of the amino terminal and transmembrane domains in the rate of CD4(+) T cell loss in macaques. Ruiz A, Schmitt K, Culley N, Stephens EB. Virology; 2013 Jan 20; 435(2):395-405. PubMed ID: 23218949 [Abstract] [Full Text] [Related]
17. Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques. Liu ZQ, Muhkerjee S, Sahni M, McCormick-Davis C, Leung K, Li Z, Gattone VH, Tian C, Doms RW, Hoffman TL, Raghavan R, Narayan O, Stephens EB. Virology; 1999 Aug 01; 260(2):295-307. PubMed ID: 10417264 [Abstract] [Full Text] [Related]
18. Fatal immunopathogenesis by SIV/HIV-1 (SHIV) containing a variant form of the HIV-1SF33 env gene in juvenile and newborn rhesus macaques. Luciw PA, Mandell CP, Himathongkham S, Li J, Low TA, Schmidt KA, Shaw KE, Cheng-Mayer C. Virology; 1999 Oct 10; 263(1):112-27. PubMed ID: 10544087 [Abstract] [Full Text] [Related]
19. Stimulation of heterologous protein degradation by the Vpu protein of HIV-1 requires the transmembrane and cytoplasmic domains of CD4. Buonocore L, Turi TG, Crise B, Rose JK. Virology; 1994 Oct 10; 204(1):482-6. PubMed ID: 8091684 [Abstract] [Full Text] [Related]
20. Presence of Intact vpu and nef genes in nonpathogenic SHIV is essential for acquisition of pathogenicity of this virus by serial passage in macaques. Mackay GA, Niu Y, Liu ZQ, Mukherjee S, Li Z, Adany I, Buch S, Zhuge W, McClure HM, Narayan O, Smith MS. Virology; 2002 Mar 30; 295(1):133-46. PubMed ID: 12033772 [Abstract] [Full Text] [Related] Page: [Next] [New Search]